Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
Re: Ergot derivatives used to treat Parkinson's disease can be linked to lung disease.
Well John, Since I take several of the things listed below, would you say right off hand that I'm Da***ed if I do and Da***ed if I don't?
Just me, Marjorie definitely a Parkie 67/58/55
The Australian, a national newspaper in Sydney, reported the following today:
Ergot derivatives used to treat Parkinson's disease can be linked to lung disease.
Bromocriptine/Parlodel and pergolide/Permax are ergot derivatives.
The source is:
Medicines leaving patients breathless By BELINDA HICKMAN 31aug00
MORE than 300 common drugs have been identified as causing lung diseases, such as coughing and asthma, prompting warnings that doctors are not sufficiently aware of the medicines' potential for causing serious side effects.
The first World Congress on Lung Health and Respiratory Diseases, which began in Florence yesterday, has heard that hundreds of drugs supplied for disorders including high blood pressure, allergies, rheumatism, infections and cancer can cause lung diseases.
The effects may occur quickly or over a long period of time. If problems are identified, patients are advised to stop or change medications.
Symptoms usually subside if the side effect is identified early, but long-term lung scarring can occur if the problem is not picked up quickly.
French physician Philippe Camus, of the University Medical Centre in Dijon, told the congress he had found at least 50 lung diseases and syndromes including coughs, breathlessness, pleurisy and acute respiratory failure that could be caused, or aggravated by, common medicines. He said 310 drugs had so far been identified as affecting the lungs.
"This means the number is really much greater if you consider that each active principle in a preparation is usually marketed in several different forms," Professor Camus said in a statement distributed by the congress, which is being attended by 15,000 specialists from 84 countries.
"The problem was practically unknown 25 years ago, but it is now taking on alarming proportions."
Australian specialists yesterday supported Professor Camus's findings, warning that doctors and patients needed to be more aware of the onset of respiratory symptoms such as coughing, breathlessness, wheezing and chest pains when beginning a medication.
Australian Lung Foundation national chairman Bob Edwardes said he saw four to five patients a year who had developed lung disease symptoms from taking a new medicine.
"Australia-wide, there would probably be several hundred cases a year. It is a significant problem and one that is not very well recognised," Dr Edwardes said.
"The message for patients who have started a new treatment, or doctors seeing people coming back with wheezing, breathlessness or coughing, is that you must consider the drug is causing the trouble."
Professor Camus's team has created a website (www.pneumotox.com), which lists drugs according to the number of reports of adverse lung events made about them.
Drug categories linked to pulmonary diseases:
Beta-blockers for high blood pressure
ACE-inhibitors for congestive heart failure and high blood pressure
Antibiotics
Non-steroidal, anti-inflammatory painkillers
Anti-cancer medications
Anti-depressants
Ergot derivatives used to treat Parkinson's disease.
jcott@xxxxxxxxx Search the parkinsn archive online at: http://james.parkinsons.org.uk Catch the Parkinsn's List Online messages at: Click the navigation ads and use the new search tools John Cottingham
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance
